Clinical Trials in North Carolina

Showing 7201-7220 of 20,428 trials

Targeted Therapy in Treating Patients With Incurable Non-Small Cell Lung Cancer With Genetic Mutations

NCT02949843

This phase II trial studies how well targeted therapy works in treating patients with incurable non-small cell lung cancer with a genetic mutation. Giving drugs that target other genetic mutations or other specific proteins may work better when a patient has cancer caused by a driver mutation and the treatment that targets that mutation stops working.

EGFR Activating MutationRecurrent Non-Small Cell Lung CarcinomaStage IV Non-Small Cell Lung Cancer

Wake Forest University Health Sciences19 participantsStarted Mar 2017

Winston-Salem, North Carolina, United States

COMPLETED41 miles

TRC-PAD Program: In-Clinic Trial-Ready Cohort

NCT04004767

The purpose of the TRC-PAD study is to develop a large, well-characterized, biomarker-confirmed, trial-ready cohort to facilitate rapid enrollment into AD prevention trials utilizing the APT Webstudy and subsequent referral to in-clinic evaluation and biomarker confirmation. Participants with known biomarker status may have direct referral to the Trial-Ready Cohort. If you are interested in being selected for the TRC-PAD study, you should first enroll in the APT Webstudy (https://www.aptwebstudy.org/welcome).

Preclinical Alzheimer's DiseaseProdromal Alzheimer's DiseaseAlzheimer Disease+1 more

University of Southern California220 participantsStarted Jun 2019

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Sun City, Arizona, United States +42 more locations

Targeted Therapy in Treating Patients With Incurable Non-Small Cell Lung Cancer With Genetic Mutations

TRC-PAD Program: In-Clinic Trial-Ready Cohort

Find Trials by Condition in North Carolina

Menthol and Mint Experimental Tobacco Marketplace (ETM) Study

Efficacy and Safety of Efavaleukin Alfa in Subjects With Active Systemic Lupus Erythematosus

Efficacy and Safety of AG10 in Subjects With Transthyretin Amyloid Cardiomyopathy

Using Point-of-Care-Ultrasound (POCUS) to Assess Gastric Contents Among Fasting Pre-operative Patients Taking GLP-1 Agonists.

Validation of Patient Reported Outcome Measures in Participants With Nontuberculous Mycobacterial Lung Infection Caused by Mycobacterium Avium Complex

Down Syndrome Clinical Trials - Study of Alzheimer's Disease in Down Syndrome

Study of Pegloticase in Participants With Uncontrolled Gout Who Have Had a Kidney Transplant

The DES BTK Vascular Stent System vs PTA in Subjects With Critical Limb Ischemia

A Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of Subcutaneous Administration of the Fixed-Dose Combination of Pertuzumab and Trastuzumab in Combination With Chemotherapy in Participants With HER2-Positive Early Breast Cancer

Safety and Efficacy of Oral Etrasimod in Adult Participants With Moderate-to-Severe Alopecia Areata

AN0025 and Pembrolizumab Combination in Advanced Solid Tumors

Pegloticase and Methotrexate Co-administered in Participants With Uncontrolled Gout Who Previously Failed Pegloticase Monotherapy

A Clinical Study to Learn if SEP-363856 Has Physical Dependence in Adults With Schizophrenia

A Study With TEPEZZA in Patients With Diffuse Cutaneous Systemic Sclerosis (dcSSc)

R-ICE and Lenalidomide in Treating Patients With First-Relapse/Primary Refractory Diffuse Large B-Cell Lymphoma

A Clinical Trial Study to Determine the Effect of an Investigational Drug (SEP-363856) Has on the Way That the Drug Metformin Travels Through the Body in People With Schizophrenia.

Fibricheck Detection cApabilities for Atrial Fibrillation

Treatment of Graves' Orbitopathy to Reduce Proptosis With Teprotumumab Infusions in an Open-Label Clinical Extension Study